• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌与临终关怀:侵袭性住院治疗的系统评价和主题综合分析。

Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care.

机构信息

Pneumologie, Hopital d'Instruction des Armees Percy, Clamart, France

Service de Pneumologie, Centre Hospitalier Intercommunal de Creteil, Creteil, France.

出版信息

BMJ Support Palliat Care. 2019 Dec;9(4):413-424. doi: 10.1136/bmjspcare-2019-001770. Epub 2019 Aug 31.

DOI:10.1136/bmjspcare-2019-001770
PMID:31473652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6923940/
Abstract

OBJECTIVES

Despite recent advances in thoracic oncology, most patients with metastatic lung cancer die within months of diagnosis. Aggressiveness of their end-of-life (EOL) care has been the subject of numerous studies. This study was undertaken to evaluate the literature on aggressive inpatient EOL care for lung cancer and analyse the evolution of its aggressiveness over time.

METHODS

A systematic international literature search restricted to English-language publications used terms associated with aggressiveness of care, EOL and their synonyms. Two independent researchers screened for eligibility and extracted all data and another a random 10% sample of the abstracts. Electronic Medline and Embase databases were searched (2000-20 September 2018). EOL-care aggressiveness was defined as follows: 1) chemotherapy administered during the last 14 days of life (DOL) or new chemotherapy regimen during the last 30 DOL; 2) >2 emergency department visits; 3) >1 hospitalisation during the last 30 DOL; 4) ICU admission during the last 30 DOL and 5) palliative care started <3 days before death.

RESULTS

Among the 150 articles identified, 42 were retained for review: 1 clinical trial, 3 observational cohorts, 21 retrospective analyses and 17 administrative data-based studies. The percentage of patients subjected to aggressive therapy seems to have increased over time. Early management by palliative care teams seems to limit aggressive care.

CONCLUSIONS

Our analysis indicated very frequent aggressive EOL care for patients with lung cancer, regardless of the definition used. The extent of that aggressiveness and its impact on healthcare costs warrant further studies.

摘要

目的

尽管胸部肿瘤学近年来取得了进展,但大多数转移性肺癌患者在确诊后数月内死亡。他们临终关怀的积极性一直是许多研究的主题。本研究旨在评估有关肺癌积极的住院临终关怀的文献,并分析其随时间推移的积极性演变。

方法

采用与关怀积极性、临终关怀及其同义词相关的术语,对英语文献进行了系统的国际文献检索。两名独立研究人员筛选合格文献并提取所有数据,另一名研究人员随机抽取 10%的摘要样本。检索了电子 Medline 和 Embase 数据库(2000 年至 2018 年 9 月 20 日)。临终关怀积极性定义如下:1)生命最后 14 天内给予化疗或生命最后 30 天内给予新的化疗方案;2)急诊就诊>2 次;3)生命最后 30 天内住院>1 次;4)生命最后 30 天内入住 ICU;5)临终关怀开始<3 天前死亡。

结果

在确定的 150 篇文章中,有 42 篇被保留用于审查:1 项临床试验、3 项观察性队列研究、21 项回顾性分析和 17 项基于行政数据的研究。接受积极治疗的患者比例似乎随着时间的推移而增加。姑息治疗团队的早期管理似乎限制了积极治疗。

结论

我们的分析表明,无论使用何种定义,肺癌患者的临终关怀都非常积极。这种积极性的程度及其对医疗保健成本的影响值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f2/6923940/38cf8b4f556b/bmjspcare-2019-001770f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f2/6923940/38cf8b4f556b/bmjspcare-2019-001770f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28f2/6923940/38cf8b4f556b/bmjspcare-2019-001770f01.jpg

相似文献

1
Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care.肺癌与临终关怀:侵袭性住院治疗的系统评价和主题综合分析。
BMJ Support Palliat Care. 2019 Dec;9(4):413-424. doi: 10.1136/bmjspcare-2019-001770. Epub 2019 Aug 31.
2
Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.与肺癌患者临终关怀的攻击性及其相关护理费用相关的因素。
Clin Lung Cancer. 2021 May;22(3):e320-e328. doi: 10.1016/j.cllc.2020.05.017. Epub 2020 May 23.
3
Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.姑息性化疗影响临终关怀的积极性。
Oncologist. 2016 Jun;21(6):771-7. doi: 10.1634/theoncologist.2015-0445. Epub 2016 Apr 18.
4
Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.潜类分析确定了三种激进临终关怀亚型:台湾的一项基于人群的研究。
Eur J Cancer. 2013 Oct;49(15):3284-91. doi: 10.1016/j.ejca.2013.05.005. Epub 2013 Jun 4.
5
Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life.早期姑息治疗转诊、住院临终关怀利用与临终时积极治疗之间的关联。
J Palliat Med. 2015 Mar;18(3):270-3. doi: 10.1089/jpm.2014.0132. Epub 2014 Sep 11.
6
Timing of palliative care referral and aggressive cancer care toward the end-of-life in pancreatic cancer: a retrospective, single-center observational study.胰腺癌患者生命终末期姑息治疗和积极抗癌治疗的时机:一项回顾性、单中心观察研究。
BMC Palliat Care. 2019 Jan 28;18(1):13. doi: 10.1186/s12904-019-0399-4.
7
Impact of Palliative Care on Quality of End-of-Life Care Among Brazilian Patients With Advanced Cancers.姑息治疗对巴西晚期癌症患者临终关怀质量的影响。
J Pain Symptom Manage. 2020 Jan;59(1):39-48. doi: 10.1016/j.jpainsymman.2019.08.021. Epub 2019 Aug 23.
8
Palliative care integration and end-of-life care intensity for patients with NSCLC.非小细胞肺癌患者的姑息治疗整合和临终关怀强度。
Lung Cancer. 2024 Jun;192:107800. doi: 10.1016/j.lungcan.2024.107800. Epub 2024 Apr 24.
9
Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population.姑息治疗服务对退伍军人事务癌症患者临终关怀激进程度的影响。
J Palliat Med. 2011 Nov;14(11):1231-5. doi: 10.1089/jpm.2011.0131. Epub 2011 Aug 30.
10
Impacts of multidisciplinary meeting case discussion on palliative care referral and end-of-life care in lung cancer: a retrospective observational study.多学科会议病例讨论对肺癌姑息治疗转诊及临终关怀的影响:一项回顾性观察研究
Intern Med J. 2021 Sep;51(9):1450-1456. doi: 10.1111/imj.15215.

引用本文的文献

1
Dual balanced augmented topological noncoding RNA disease triplet association in heterogeneous graphs.异质图中的双平衡增强拓扑非编码RNA疾病三联体关联
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf389.
2
Cost Disparities with Age in the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) in Ontario, Canada.加拿大安大略省晚期非小细胞肺癌(NSCLC)治疗中年龄相关的费用差异
Curr Oncol. 2025 Jun 12;32(6):346. doi: 10.3390/curroncol32060346.
3
Trajectory of quality of life among patients with cancer at the end of life: a longitudinal survey study.

本文引用的文献

1
One Step Forward, Two Steps Back: Trends in Aggressive Inpatient Care at the End of Life for Patients With Stage IV Lung Cancer.一步之遥,事与愿违:IV 期肺癌患者临终时积极住院治疗的趋势。
J Oncol Pract. 2018 Dec;14(12):e746-e757. doi: 10.1200/JOP.18.00515. Epub 2018 Sep 28.
2
Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.针对65岁以下转移性癌症患者的积极临终关怀。
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx028.
3
Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced Cancer.
临终癌症患者的生活质量轨迹:一项纵向调查研究。
Qual Life Res. 2025 Feb 18. doi: 10.1007/s11136-025-03923-0.
4
Palliative care for chronic respiratory diseases in low- and middle-income countries: a narrative review.低收入和中等收入国家慢性呼吸道疾病的姑息治疗:一项叙述性综述
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251318616. doi: 10.1177/17534666251318616.
5
Scoping review of anticancer drug utilization in lung cancer patients at the end of life.终末期肺癌患者抗癌药物使用情况的范围综述
Clin Transl Oncol. 2025 May;27(5):1980-1993. doi: 10.1007/s12094-024-03711-1. Epub 2024 Oct 5.
6
Associations between palliative-care consultations and end-of-life quality in cancer patients' last 6 months.癌症患者临终前 6 个月的姑息治疗咨询与生命末期质量的关联。
Support Care Cancer. 2024 Aug 21;32(9):606. doi: 10.1007/s00520-024-08814-7.
7
Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors.晚期实体瘤患者的全身抗癌治疗与总生存期
JAMA Oncol. 2024 Jul 1;10(7):887-895. doi: 10.1001/jamaoncol.2024.1129.
8
Anticancer therapy at end-of-life: A retrospective cohort study.临终前的抗癌治疗:一项回顾性队列研究。
Acta Oncol. 2024 May 8;63:313-321. doi: 10.2340/1651-226X.2024.22139.
9
Prevalence of aggressive care among patients with cancer near the end of life: a systematic review and meta-analysis.癌症晚期患者积极治疗的患病率:一项系统评价和荟萃分析。
EClinicalMedicine. 2024 Mar 21;71:102561. doi: 10.1016/j.eclinm.2024.102561. eCollection 2024 May.
10
Racial and Ethnic Disparities in Intensity of Care at the End of Life for Patients With Lung Cancer: A 13-Year Population-Based Study.肺癌患者临终时护理强度的种族和族裔差异:一项基于人群的13年研究。
J Clin Oncol. 2024 May 10;42(14):1646-1654. doi: 10.1200/JCO.23.01045. Epub 2024 Mar 13.
姑息治疗对晚期癌症患者临终关怀攻击性的影响。
J Oncol Pract. 2017 Sep;13(9):e760-e769. doi: 10.1200/JOP.2017.020883. Epub 2017 Aug 22.
4
End-of-life chemotherapy use at a Finnish university hospital: a retrospective cohort study.芬兰一家大学医院临终化疗的使用情况:一项回顾性队列研究。
Acta Oncol. 2017 Oct;56(10):1272-1276. doi: 10.1080/0284186X.2017.1332424. Epub 2017 May 31.
5
Association between aggressive care and bereaved families' evaluation of end-of-life care for veterans with non-small cell lung cancer who died in Veterans Affairs facilities.积极治疗与在退伍军人事务设施中死亡的非小细胞肺癌退伍军人临终关怀的丧亲家庭评估之间的关联。
Cancer. 2017 Aug 15;123(16):3186-3194. doi: 10.1002/cncr.30700. Epub 2017 Apr 17.
6
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌临床实践指南(2017 年第 5 版),NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2017 Apr;15(4):504-535. doi: 10.6004/jnccn.2017.0050.
7
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial.早期综合姑息治疗对肺癌和胃肠道癌患者的影响:一项随机临床试验
J Clin Oncol. 2017 Mar 10;35(8):834-841. doi: 10.1200/JCO.2016.70.5046. Epub 2016 Dec 28.
8
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.
9
Association of Palliative Care Consultation With Reducing Inpatient Chemotherapy Use in Elderly Patients With Cancer in Japan: Analysis Using a Nationwide Administrative Database.日本姑息治疗咨询与减少老年癌症患者住院化疗使用的关联:基于全国行政数据库的分析
Am J Hosp Palliat Care. 2017 Aug;34(7):685-691. doi: 10.1177/1049909116650238. Epub 2016 May 19.
10
Family Perspectives on Aggressive Cancer Care Near the End of Life.家庭对临终前积极癌症治疗的看法。
JAMA Oncol. 2016 Jul 1;2(7):957-8. doi: 10.1001/jamaoncol.2016.0441.